ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $251,000 | -57.9% | 11,861 | -44.2% | 0.08% | -59.8% |
Q1 2021 | $596,000 | -50.4% | 21,253 | -54.0% | 0.19% | -56.7% |
Q4 2020 | $1,201,000 | -30.1% | 46,181 | 0.0% | 0.45% | -46.0% |
Q3 2020 | $1,717,000 | -27.6% | 46,181 | 0.0% | 0.83% | -34.6% |
Q2 2020 | $2,370,000 | +62.8% | 46,181 | 0.0% | 1.27% | +50.5% |
Q1 2020 | $1,456,000 | -53.8% | 46,181 | -12.6% | 0.84% | -39.1% |
Q4 2019 | $3,150,000 | +62.6% | 52,826 | 0.0% | 1.38% | +70.7% |
Q3 2019 | $1,937,000 | -21.2% | 52,826 | 0.0% | 0.81% | -33.4% |
Q2 2019 | $2,457,000 | +15.8% | 52,826 | 0.0% | 1.22% | +8.5% |
Q1 2019 | $2,121,000 | +113.8% | 52,826 | +145.0% | 1.12% | +29.8% |
Q4 2018 | $992,000 | +99100.0% | 21,562 | 0.0% | 0.86% | +112.5% |
Q3 2018 | $1,000 | 0.0% | 21,562 | 0.0% | 0.41% | -55.2% |
Q2 2018 | $1,000 | -50.0% | 21,562 | -31.7% | 0.91% | -42.7% |
Q1 2018 | $2,000 | -100.0% | 31,562 | -72.6% | 1.59% | -59.5% |
Q4 2017 | $7,594,000 | +289.4% | 115,344 | +383.7% | 3.92% | +433.0% |
Q2 2015 | $1,950,000 | +343.2% | 23,847 | +401.4% | 0.74% | +266.2% |
Q1 2015 | $440,000 | – | 4,756 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |